Delivery Order SPE2DB22D6029-SPE2DB24FU0DC
Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $4.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $5,617.92 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564391256 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceuticals. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,872.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of March 5, 2024. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) between...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $27,368.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. This delivery order falls under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,021,744 units of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract, valued at $11,809.01, has a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,044.43 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine, with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,052.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 25 mcg/0.5 mL TYPHIM VI syringes by May 1, 2024. This award is under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,421.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,368.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4564360612 - TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with an ultimate completion date of April 23, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, including the Department of Defense and Department of Veterans...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a specialty pharmaceutical product, with a potential value of $12,298.44 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- This federal contract award, valued at $5,404.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of June 26, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0DCDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,681.60 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation, for the supply of 4563795308 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Generated 5/29/24, 9:37 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 2/28/24 |